Single institution experience of over 100 cases of augmentation enterocystoplasty in the patients with end-stage bladder diseases

Single institution experience of over 100 cases of augmentation enterocystoplasty in the patients with end-stage bladder diseases

Bibliographic Details
Main Authors:	Shu-Yu Wu, Jia-Fong Jhang, Hann-Chorng Kuo
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-06-01
Series:	Urological Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S1879522616301579

Similar Items

Long-term Outcomes of Augmentation Enterocystoplasty in Patients With End-Stage Bladder Diseases: A Single-Institute Experience Involving 102 Patients
by: Shu-Yu Wu, et al.
Published: (2017-06-01)

Clinical outcome of augmentation enterocystoplasty for patients with ketamine-induced cystitis
by: Yu Khun Lee, et al.
Published: (2016-06-01)

Long-term Outcomes of Augmentation Enterocystoplasty with an Ileal Segment in Patients with Spinal Cord Injury
by: Jing-Liang Chen, et al.
Published: (2009-06-01)

The Current Positioning of Augmentation Enterocystoplasty in the Treatment for Neurogenic Bladder
by: Seong Jin Jeong, et al.
Published: (2020-09-01)

Augmentation enterocystoplasty without reimplantation for patients with neurogenic bladder and vesicoureteral reflux
by: Han-Chao Zhang, et al.
Published: (2016-06-01)

Pregnancy and delivery after augmentation enterocystoplasty: a case report
by: Odeta Bobelytė, et al.
Published: (2014-04-01)

Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease
by: Jia-Fong Jhang, et al.
Published: (2016-11-01)

Role of serum immunoglobulin E in patients with interstitial cystitis/bladder pain syndrome
by: Jia-Fong Jhang, et al.
Published: (2015-09-01)

Histopathological classification of ketamine related cystitis in different bladder condition and the association with treatment outcome
by: Jia-Fong Jhang, et al.
Published: (2016-06-01)

Rare neuroendocrine tumor decades after bladder exstrophy repair with enterocystoplasty
by: Sabine Roux, et al.
Published: (2018-04-01)

Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection
by: Jia-Fong Jhang, et al.
Published: (2015-06-01)

Novel Applications of Non-Invasive Intravesical Botulinum Toxin a Delivery in the Treatment of Functional Bladder Disorders
by: Jia-Fong Jhang, et al.
Published: (2021-05-01)

Reduction of cystometric bladder capacity and bladder compliance with time in patients with end-stage renal disease
by: Jing-Liang Chen, et al.
Published: (2012-04-01)

Reduction of urgency severity is the most important factor in the subjective therapeutic outcome of intravesical onabotulinumtoxina injection for overactive bladder
by: Jia-Fong Jhang, et al.
Published: (2015-12-01)

Clinical characteristics and immunochemical study of urothelial dysfunction in the patients with interstitial cystitis/bladder pain syndrome with and without hunner's lesion
by: Jia-Fong Jhang, et al.
Published: (2015-06-01)

Increased bladder wall thickness is associated with severe symptoms and reduced bladder capacity in patients with bladder pain syndrome
by: Shu-Yu Wu, et al.
Published: (2016-12-01)

Long-term functional outcomes and complications of augmentation enterocystoplasty in adult patients with neurogenic bladder: A single-center experience in a multidisciplinary team
by: T. Batard, et al.
Published: (2020-07-01)

The genetic basis of carcinogenesis in the clam enterocystoplasty
by: Ivil, Kenneth Douglas
Published: (2007)

Comparison of Enterocystoplasty and Ureterocystoplasty before Kidney Transplantation
by: R. Mahdavi Zafarghandi, et al.
Published: (2010-10-01)

Pregnancy With a Successful Vaginal Delivery Following Augmentation Enterocystoplasty for Ketamine Cystitis: A Case Report
by: Chiung-Hui Peng, et al.
Published: (2016-12-01)

Current pharmacological and surgical treatment of underactive bladder
by: Yuan-Hong Jiang, et al.
Published: (2017-01-01)

Individualizing medical treatment of overactive bladder
by: Hann-Chorng Kuo
Published: (2018-01-01)

Treatment of overactive bladder: Past, present, and future
by: Hann-Chorng Kuo
Published: (2015-03-01)

Ultrastructural changes in the underactive bladder
by: Han-Chen Ho, et al.
Published: (2021-01-01)

Body contouring abdominoplasty for augmentation enterocystoplasty with continent cutaneous urinary diversion in an obese adolescent patient: A case report
by: di Summa, P.G, et al.
Published: (2022)

Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction
by: Jia-Fong Jhang, et al.
Published: (2018-06-01)

Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action
by: Jia-Fong Jhang, et al.
Published: (2016-04-01)

Recent advances in recurrent urinary tract infection from pathogenesis and biomarkers to prevention
by: Jia-Fong Jhang, et al.
Published: (2017-01-01)

Urothelial dysfunction and sensory protein expressions in ketamine cystitis – comparision with interstitial cystitis
by: Jia-Fong Jhang, et al.
Published: (2015-06-01)

Long-term follow up and predictive factors for successful outcome of transurethral incision of the bladder neck in women with detrusor underactivity
by: Jia-Fong Jhang, et al.
Published: (2016-09-01)

Alternatives to conventional enterocystoplasty in children. A critical review of urodynamic outcomes.
by: Ricardo eGonzález, et al.
Published: (2013-10-01)

Smaller bladder capacity and stronger bladder contractility in patients with ketamine cystitis are associated with elevated TRPV1 and TRPV4
by: Hsueh-Hui Yang, et al.
Published: (2021-03-01)

Anthropometric measurements as an indicator of nutritional status in spina bifida patients undergoing enterocystoplasty
by: Silvia Ferraz Ayrosa Ponte, et al.

Urothelial dysfunction and chronic inflammation in patients with bladder outlet obstruction and different bladder dysfunction and different BOO degree
by: Cheng-Ling Lee, et al.
Published: (2015-06-01)

Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm
by: Yuan-Hong Jiang, et al.
Published: (2021-01-01)

Adverse Events of Intravesical Onabotulinum Toxin A Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
by: Yuh-Chen Kuo, et al.
Published: (2016-03-01)

Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men - A comparison of men with normal tracing and bladder outlet obstruction.
by: Yuan-Hong Jiang, et al.
Published: (2017-01-01)

Managing intractable incontinence from a Yang-Monti channel in a case of enterocystoplasty with bladder neck closure – Challenges and a modified surgical technique
by: Murali Krishna Padyala, et al.
Published: (2021-01-01)

Biomarkers for patients with interstitial cystitis/bladder pain syndrome
by: Hsin-Tzu Liu, et al.
Published: (2015-12-01)

Electron microscopic characteristics of interstitial cystitis/bladder pain syndrome and their association with clinical condition.
by: Jia-Fong Jhang, et al.
Published: (2018-01-01)